Handelsavisen
prelaunch
A
A.O NYSE Unclassified

Agilent Technologies Inc

$130,60
Open in Charts → Attach watcher ⌖
USD
Set alert
LatestBYD and Xiaomi shares surge on strong June EV delivery data
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
37,0B USD
P/E
26,7x
EV / Rev
5,4x
Div yield
0,76 %
Op margin
21,3 %
ROE
19,3 %
Net margin
18,8 %
Debt / equity
0,45
Beta
52w range
Volume
Day range
Prev close
$133,39
Open
Next earnings
2026-08-28
Ex-dividend
TR 1Y
About

Agilent Technologies Inc operates as a life sciences, diagnostics, and applied chemical markets company, generating revenue through the sale of instruments, consumables, and services to research and industrial customers.

Business. Agilent Technologies Inc operates as a life sciences, diagnostics, and applied chemical markets company, generating revenue through the sale of instruments, consumables, and services to research and industrial customers.

Classification20 %
SectorUnclassified
Generated · model-assisted
Sell-side consensus
BUY22 analysts
17 buy5 hold0 sell
Avg 12m price target160,24

Analyst recommendations

22 analysts · consensus Buy
Buy17
Hold5
Sell0
12-month price target
160,24
Consensus of sell-side coverage.
Upcoming events
  • EarningsQ3 2026 earnings (expected)2026-08-28 · estimated
See all catalysts →

At a glance

Score
62
composite score
Valuation
26,7x
P/E
Analysts
Buy
22 analysts · indicative
Ownership
T. Rowe Price Investment Management, Inc.
largest disclosed fund holder
Profitability
19,3 %
return on equity
Quality
60
quality score (0-100)

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

6
  • MARKETSBYD and Xiaomi shares surge on strong June EV delivery data2026-07-02
  • MARKETSMicron plunges 11% as chip sector opens Q3 with sharp reversal2026-07-01
  • MARKETSMicron and SanDisk lead semiconductor selloff as AI trade faces stress test2026-07-01
  • MARKETSMicron and GM sign vehicle memory supply deal as sector rallies2026-07-01
  • MARKETSKospi opens higher as chip rally extends on Micron earnings tailwind2026-07-01
  • MARKETSSeoul stocks open higher as chip rally extends into Wednesday session2026-07-01
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,2 %+1,6 %+2,4 %
    Energy+1,2 %+5,3 %+1,4 %
    Real Estate+0,7 %+4,1 %+0,8 %
    Health Care · THIS SECTOR+0,6 %−0,5 %+0,8 %
    Consumer Discretionary+0,3 %+8,7 %+0,5 %
    Information Technology−0,3 %+6,5 %−0,1 %
    Financials−0,3 %−4,5 %−0,1 %
    Consumer Staples−1,0 %+3,0 %−0,8 %
    Utilities−1,5 %−21,2 %−1,3 %
    Industrials−1,7 %−2,3 %−1,6 %
    Communication Services

    Developing storylines

    low
    AI Investment Scrutiny
    8 posts
    low
    Asia Chip Market Shift
    4 posts
    low
    AI Chip Market Volatility
    4 posts

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-07-07 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Company
    • EarningsQ3 2026 earnings (expected)2026-08-28 · estimated
    • Macro
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-07-08 · AU
    • Rate decisionBank of Canada rate decision (press conf.)2026-07-15 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-07-16 · EU
    • Rate decisionBank of Japan rate decision (press conf.)2026-07-16 · JP
    • Rate decisionFederal Reserve rate decision (press conf.)2026-07-29 · US
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR
    • Congressional trades
    • CongressLisa McClain — Agilent Technologies, Inc. Common2025-07-16 · Republican · MI · Sale · $1,001 - $15,000
    • CongressLisa McClain — Agilent Technologies, Inc. Common2025-06-17 · Republican · MI · Purchase · $1,001 - $15,000
    • CongressJulie Johnson — Agilent Technologies, Inc. Common2025-04-01 · Democrat · TX · Sale · $1,001 - $15,000
    • CongressJulie Johnson — Agilent Technologies, Inc. Common2025-03-03 · Democrat · TX · Sale · $1,001 - $15,000

    Pre-earnings brief

    Briefing · model-assisted

    The provided facts contain a critical contradiction that prevents the generation of a valid synthesis for Micron Technology Inc. The `COMPANY_360` data explicitly identifies the entity as "Agilent Technologies Inc," not Micron Technology Inc. Furthermore, the `MATERIAL_CHANGES` section states there is "no prior basis for delta computation," and the `WATCHER_SIGNALS` display conflicting data for the same investor (ID 587) on the same date (2026-03-31), showing both a reduction from 170,191 to 864 shares and an increase from 864 to 170,191 shares. Because the company name in the facts does not match the requested ticker (Micron Technology Inc), and the data signals are internally inconsistent and lack a clear directional change, no factual synthesis can be constructed. The instructions strictly prohibit inventing events, numbers, or assertions not supported by the facts. Consequently, it is not possible to lead with a material change or explain its significance using the provided `COMPANY_360` spine for Micron Technology Inc. The available data pertains to Agilent Technologies Inc and contains ambiguous holder activity that cannot be reliably interpreted as a single material event. Therefore, no synthesis text can be outputted that adheres to the constraint of using ONLY the provided facts without inventing information or misidentifying the company. The request cannot be fulfilled as stated due to the mismatch between the target company and the provided data.

    Signals & dispatch

    peak dispatch · 2026-06-25

    Composite-score breakdown

    Score breakdown62
    Valuation+8
    Profitability+27
    Sentiment+30
    Risk penalty−3

    Synthesis

    Business

    Agilent Technologies Inc operates as a life sciences, diagnostics, and applied chemical markets company, generating revenue through the sale of instruments, consumables, and services to research and industrial customers.

    Classification20 %
    SectorUnclassified
    AI synthesis
    GENERATED

    Agilent Technologies maintains a balanced capital structure with total assets of $12.73 billion and total liabilities of $5.99 billion, resulting in total equity of $6.74 billion. The company holds $1.79 billion in cash and equivalents against $3.05 billion in long-term debt, creating a net debt position that triggers a medium liquidity risk flag. The debt-to-equity ratio stands at 0.45, indicating moderate leverage, while the current ratio is not explicitly provided but implied stable given the operating cash flow of $1.56 billion. The market capitalization is $37.80 billion, reflecting a premium valuation with a price-to-earnings ratio of 29.01 and an EV/EBITDA of 26.41.

    Profitability metrics demonstrate strong returns, with a return on equity of 19.33% and a return on assets of 10.24%. The company generated $1.30 billion in net income on $6.95 billion in revenue, yielding a net margin of approximately 18.75%. Operating income was $1.48 billion, supporting robust cash generation. The price-to-book ratio of 5.61 suggests investors are pricing in high-quality earnings and durable competitive advantages, consistent with the strong ROE.

    Segment and geographic data are not provided in the current input, preventing a detailed analysis of revenue concentration or regional exposure. The company’s business model likely relies on a mix of recurring consumable sales and capital equipment, typical for the life sciences and diagnostics sector, but specific segment contributions cannot be quantified from the available data.

    Growth trajectory analysis is limited by the absence of historical period data in the input. The current revenue base of $6.95 billion serves as the baseline for future projections. Without year-over-year or quarter-over-quarter historical trends, the specific growth rate cannot be calculated, though the strong analyst consensus suggests positive expectations for future performance.

    Risk assessment highlights medium liquidity risk due to the net debt position, where total debt exceeds cash and equivalents. Dilution risk is assessed as low, with basic and diluted shares outstanding both at 283.05 million, indicating no significant share-based compensation impact or recent issuances. The key flag notes that net cash is negative after subtracting total debt, which requires monitoring of interest coverage and refinancing needs.

    Recent observations indicate strong analyst support, with a mean recommendation of 1.96 (close to buy) and a mean price target of $160.49, implying significant upside from the current market price of $133.53. The high price target of $185.00 and low of $144.00 show a wide range of expectations, but the consensus leans bullish with 6 strong buys and 12 buys versus 5 holds.

    The provided facts contain a critical contradiction that prevents the generation of a valid synthesis for Micron Technology Inc. The `COMPANY_360` data explicitly identifies the entity as "Agilent Technologies Inc," not Micron Technology Inc. Furthermore, the `MATERIAL_CHANGES` section states there is "no prior basis for delta computation," and the `WATCHER_SIGNALS` display conflicting data for the same investor (ID 587) on the same date (2026-03-31), showing both a reduction from 170,191 to 864 shares and an increase from 864 to 170,191 shares. Because the company name in the facts does not match the requested ticker (Micron Technology Inc), and the data signals are internally inconsistent and lack a clear directional change, no factual synthesis can be constructed. The instructions strictly prohibit inventing events, numbers, or assertions not supported by the facts. Consequently, it is not possible to lead with a material change or explain its significance using the provided `COMPANY_360` spine for Micron Technology Inc. The available data pertains to Agilent Technologies Inc and contains ambiguous holder activity that cannot be reliably interpreted as a single material event. Therefore, no synthesis text can be outputted that adheres to the constraint of using ONLY the provided facts without inventing information or misidentifying the company. The request cannot be fulfilled as stated due to the mismatch between the target company and the provided data.

    Key takeaways
    • Agilent trades at a premium valuation with a P/E of 29.01 and EV/EBITDA of 26.41, supported by strong ROE of 19.33%.
    • The company carries a net debt position of $1.26 billion ($3.05B debt vs $1.79B cash), resulting in medium liquidity risk.
    • Analyst consensus is bullish with a mean price target of $160.49, suggesting 20% upside from the current price of $133.53.
    • Dilution risk is low with no difference between basic and diluted shares outstanding.
    • Classification confidence is low (0.20), requiring careful interpretation of industry-specific benchmarks.

    Bull / Bear case

    Generated · model-assisted
    — missing data

    In focus — financials by report

    Quarterly
    Annual
    QUARTERLYFiled 2026-05-27
    Q1 2026 · Quarter highlights
    Open report →

    Revenue $1.83B, +10,0% YoY; Operating income +40,0% YoY.

    Revenue$1.83B+10,0 % YoY
    Operating income$399.0M+40,0 % YoY
    Net income$339.0M+57,7 % YoY
    Free cash flow$258.0M+148,1 % YoY
    EPS
    Operating cash flow$545.0M−16,4 % YoY
    Financials
    Income statement
    Revenue$1.83B
    Gross profit$993.0M
    Operating income$399.0M
    Net income$339.0M
    Margins
    Gross margin54.1%
    Operating margin21.7%
    Net margin18.5%
    FCF margin14.1%
    Balance sheet
    Total assets$13.06B
    Total liabilities$5.94B
    Total equity$7.12B
    Cash & equivalents$1.81B
    Long-term debt$3.35B
    Cash flow
    Operating cash flow$545.0M
    CapEx-$169.0M
    Free cash flow$258.0M
    SBC
    P&L flow · revenue → net income
    Revenue $1.83BOperating costs $1.44BTax $60.0MNet income $339.0M
    Highlights
    • Revenue $1.83B, +10,0% YoY
    • Operating income +40,0% YoY
    • Net income +57,7% YoY
    • Free cash flow +148,1% YoY
    • Net margin 18.5%

    Valuation TTM

    Market price
    $130,60
    Market cap
    $37.80B
    Enterprise value
    $39.06B
    P/E
    26.7x
    Non-GAAP P/E
    EV / Revenue
    5.4x
    EV / Op income
    25.1x
    EV / OCF
    25.1x
    P / B
    5.6x
    P / Tangible book
    5.6x
    Tangible book
    $6.74B
    Net cash
    -$1.26B
    Current ratio
    Debt / equity
    0.5
    ROA
    10.2%
    ROE
    19.3%
    Cash conversion
    120.0%
    CapEx / revenue
    5.9%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Lab Services, Consumables & Automation41,9 %
    disclosed · sec_xbrl · 2025-10-31
    Life Sciences & Diagnostics Instruments39,2 %
    disclosed · sec_xbrl · 2025-10-31

    Market share

    INDUSTRYSEGMENTCOMPANYHealthcareIndustryAdvanced Medical Equipment & Technology170,9B node revenueTMO 26,1%DHR 14,4%GEHC 12,1%PHG 11,9%BSX 11,7%ISRG 5,9%A 4,1%EW 3,5%Other 10,4%
    Source: company disclosures · own-taxonomy revenue-covered set · attribution: collision-suspect (indicative)A 4,1% · rank #7 of 46

    Business relationships

    Business relationships10 disclosed relationships · 1 type · extracted from filings & disclosures
    Subsidiaries10
    EX21:05b635150bc3EX21:05b635150bc3Subsidiarie97%
    EX21:2832329a2a5aEX21:2832329a2a5aSubsidiarie97%
    EX21:2d330adc7459EX21:2d330adc7459Subsidiarie97%
    EX21:3f5d1c3fa3b3EX21:3f5d1c3fa3b3Subsidiarie97%
    EX21:518e81e78a35EX21:518e81e78a35Subsidiarie97%
    EX21:62c588a53e78EX21:62c588a53e78Subsidiarie97%
    EX21:ac2f3c70f055EX21:ac2f3c70f055Subsidiarie97%
    EX21:b6384db27721EX21:b6384db27721Subsidiarie97%
    EX21:edd402aa6e15EX21:edd402aa6e15Subsidiarie97%
    EX21:f733c69e2776EX21:f733c69e2776Subsidiarie97%

    Supply chain

    — missing data

    Peer comparison

    Peer comparison7 peers · vs A · multiples and returns
    TM
    TMO
    Thermo Fisher Scientific Inc
    $517,60
    195,7B USD
    P/E
    27,0x
    -2,0 vs self
    Div yield
    0,3 %
    -0,4 vs self
    ROE
    12,6 %
    -6,8 vs self
    DH
    DHR
    Danaher Corp
    $195,03
    138,7B USD
    P/E
    113,7x
    +84,7 vs self
    Div yield
    vs self
    ROE
    1,9 %
    -17,4 vs self
    GE
    GEHC
    GE HEALTHCARE TECHNOLOGIES INC.
    $64,84
    29,5B USD
    P/E
    65,6x
    +36,6 vs self
    Div yield
    0,2 %
    -0,5 vs self
    ROE
    5,5 %
    -13,8 vs self
    PH
    PHG
    PHG
    P/E
    vs self
    Div yield
    vs self
    ROE
    vs self
    BS
    BSX
    Boston Scientific Corp
    $44,61
    66,7B USD
    P/E
    23,0x
    -6,1 vs self
    Div yield
    vs self
    ROE
    11,9 %
    -7,4 vs self
    IS
    ISRG
    INTUITIVE SURGICAL, INC.
    $434,29
    153,8B USD
    P/E
    287,7x
    +258,7 vs self
    Div yield
    vs self
    ROE
    3,6 %
    -15,8 vs self
    EW
    EW
    Edwards Lifesciences Corp
    P/E
    vs self
    Div yield
    vs self
    ROE
    vs self

    Market position

    Stress test

    — missing data

    Predictor forecast

    Next quarternear-term
    Earnings · next quarterconf 33 %
    EPS
    Consensus EPS
    6,06
    Predicted surprise
    -0,02
    Beat probability
    33 %
    Analysts
    23
    Other metrics
    Revenue
    no estimate
    Segment revenue
    no estimate
    Margin
    no estimate
    Segment margin
    no estimate
    as of 2026-07-02 · Earnings Surprise V1
    Period note: consensus is not fiscal-period-aligned at source — read as consensus vs the last reported actual, not a calibrated same-quarter surprise.
    Segment revenue · next quarter
    No quarterly segment estimate
    Segment data is reported at full-fiscal-year granularity only — no quarterly segment split is forecast (a quarterly figure is never inferred from the annual). See the full-fiscal-year segment-revenue card below.
    Full fiscal year~1 year ahead
    Full fiscal year · our forecast vs guidance vs consensus
    MetricOur forecastGuidanceConsensus
    EPSno estimateno estimate5,98
    Revenueno estimateno estimate7,4B USD
    Operating incomeno estimateno estimate1,9B USD
    Full-year consensus mean (period as reported by source) · consensus in USD. Company-level full-year forecast and management guidance are not yet modelled at scale — shown as "no estimate", never inferred.
    Segment-revenue forecast · full fiscal year · native currency
    • Lab Services, Consumables & AutomationFY2026 — next full year (forecast) · projected off FY2025 close, as of 2025-10-31 · conf —3,0BFORECAST
    • Life Sciences & Diagnostics InstrumentsFY2026 — next full year (forecast) · projected off FY2025 close, as of 2025-10-31 · conf —2,8BFORECAST
    • Analytical Instruments & SoftwareFY2026 — next full year (forecast) · projected off FY2025 close, as of 2025-10-31 · conf —1,3BFORECAST
    • Life Sciences & Diagnostics InstrumentsFY2024 — reported · conf —2,8BREPORTED
    • Lab Services, Consumables & AutomationFY2025 — reported · conf —2,8BREPORTED
    • Lab Services, Consumables & AutomationFY2024 — reported · conf —2,7BREPORTED
    • Life Sciences & Diagnostics InstrumentsFY2025 — reported · conf —2,5BREPORTED
    • Analytical Instruments & SoftwareFY2024 — reported · conf —1,4BREPORTED
    • Analytical Instruments & SoftwareFY2025 — reported · conf —1,3BREPORTED
    Model estimate of reported / forward segment revenue in issuer-native currency. Confidence shown where the model calibrated it; "—" where not (never inferred).
    Corporate eventM&A horizon
    M&A probabilityconf 3 %
    Probability
    3 %
    Base rate
    3 %
    Band
    180-day horizon · target 2027-01-03 · 1,0× base rate
    No acquirer candidates identified by the signal model.
    Probabilistic model output — not investment advice. · generated 2026-07-07

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Consensus distribution

    sell-side coverage
    Recommendation distribution22 analysts
    Strong buy4
    Buy13
    Hold5
    Sell0
    Strong sell0
    12-month price target$160,24 · Median $161,17
    Low $140,00High $185,00
    Operating income · consensus1,9B USD
    EPS surprise
    −6,5 %
    reported vs consensus · miss
    Revenue surprise
    −5,9 %
    reported vs consensus · miss

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    Low$140,00
    Mean$160,24
    Median$161,17
    High$185,00
    Spot$130,60
    +22.7 %implied to mean12-month sell-side price targets · ▲ spot

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin21,3 %Above P75
    Net Margin18,8 %Above P75
    ROE19,3 %Above P75
    Capex / Rev5,9 %Best in class
    D/E0,45Below median
    Cash Conv1,20Above median

    Corporate actions / M&A

    M&A probabilityconf —
    Probability
    3 %
    Base rate
    3 %
    Band
    Low
    180-day horizon · target 2027-01-03 · 1,0× base rate
    No acquirer candidates identified by the signal model.
    Corporate actionsNo corporate-action source connected yet — splits, dividends and buyback events are not tracked for this company. Honest-dim (no data fabricated).

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    • Reference data
    How metrics are computed
    • Ev To Operating Income
      enterprise_value / operating_income
    • Capex To Revenue
      capital_expenditure / revenue
    • Price To Tangible Book
      market_price / (tangible_book_value / shares_outstanding_diluted)
    • Return On Assets
      net_income / total_assets
    • Ev To Revenue
      enterprise_value / revenue
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    Source documents
    • AGILENT TECHNOLOGIES, INC. Market data — financials · 2026-07-02
    • Agilent Technologies Inc Market data — analyst estimates · 2026-07-02
    • Agilent Technologies Inc Market data — ESG · 2026-07-02
    • Agilent Technologies Inc HA canonical relationships · 2026-07-02

    Ownership & reference

    Top holders

    • T. Rowe Price Investment Management, Inc.Investment Managers · as of 2026-03-310,71 %$1M
    • MASSACHUSETTS FINANCIAL SERVICES CO /MA/Institutional Investor · as of 2026-03-310,49 %$1 469M
    • EATON VANCE MANAGEMENTInstitutional Investor · as of 2022-09-300,17 %$0M
    • AQR Capital Management, LLCInvestment Managers · as of 2026-03-310,16 %$339M
    • Wellington Management Company, LLPInvestment Managers · as of 2026-03-310,15 %$827M
    • Arrowstreet Capital, Limited PartnershipInvestment Managers · as of 2026-03-310,09 %$164M
    • BlackRock Institutional Trust Company, N.A.Investment Managers · as of 2024-06-300,07 %$3 275M
    • Vanguard Capital Management, LLCInvestment Managers · as of 2025-12-310,07 %$4 641M
    • First Trust Advisors L.P.Investment Managers · as of 2026-03-310,06 %$90M
    • Bank of New York Mellon CorpInstitutional Investor · as of 2026-03-310,06 %$318M
    • Northern Trust Investments, Inc.Investment Managers · as of 2026-03-310,06 %$422M
    • Goldman Sachs Asset Management, L.P.Investment Managers · as of 2026-03-310,05 %$408M
    • Geode Capital Management, L.L.C.Investment Managers · as of 2026-03-310,05 %$854M
    • State Street Investment Management (US)Investment Managers · as of 2026-03-310,05 %$1 458M
    • Dimensional Fund Advisors, L.P.Investment Managers · as of 2026-03-310,05 %$240M
    • Nuveen LLCInvestment Managers · as of 2024-12-310,04 %$143M
    • Invesco QQQ TrustFunds · as of 2026-03-310,04 %$264M
    • AllianceBernstein L.P.Investment Managers · as of 2026-03-310,04 %$115M
    • Morgan Stanley Smith Barney LLCInvestment Managers · as of 2026-03-310,03 %$564M
    • Charles Schwab Investment Management, Inc.Investment Managers · as of 2026-03-310,03 %$217M
    • AMERIPRISE FINANCIAL INCInstitutional Investor · as of 2026-03-310,03 %$137M
    • Jennison Associates LLCInvestment Managers · as of 2026-03-310,03 %$39M
    • Franklin Advisers, Inc.Investment Managers · as of 2026-03-310,03 %$103M
    • Raymond James & Associates, Inc.Brokerage Firms · as of 2026-03-310,02 %$70M
    • Principal Global Investors (Equity)Investment Managers · as of 2026-03-310,02 %$40M
    • Victory Capital Management Inc.Investment Managers · as of 2026-03-310,02 %$25M
    • UBS Financial Services, Inc.Investment Managers · as of 2026-03-310,02 %$88M
    • PNC Investments LLCInvestment Managers · as of 2026-03-310,01 %$19M
    • Wells Fargo AdvisorsBrokerage Firms · as of 2026-03-310,01 %$53M
    • American Century Investment Management, Inc.Investment Managers · as of 2026-03-310,01 %$20M
    • FMR LLCInstitutional Investor · as of 2026-03-310,01 %$104M
    • T. Rowe Price Associates, Inc.Investment Managers · as of 2026-03-310,01 %$0M
    • LPL Financial LLCInvestment Managers · as of 2026-03-310,00 %$14M
    • JONES FINANCIAL COMPANIES LLLPInstitutional Investor · as of 2026-03-310,00 %$6M
    • JANUS HENDERSON GROUP PLCInstitutional Investor · as of 2026-03-310,00 %$4M
    • PNC Investments LLCInvestment Managers · as of 2026-03-310,00 %$0M

    Leadership

    • Mike R. McMullenPresident, Chief Executive Officer, Director

    Insider activity

    Net selling0 buys · 1 sellsnet -$217K9 insiders · last 365d
    • KIRKWOOD JONAH PREVOSTSenior Vice President · Common StockOther 30 @ $136,01$4K · 2026-06-26
    • MCDONNELL PADRAIGDirector, President and CEO · Common StockOther 418 @ $137,40$57K · 2026-06-03
    • Dolsten MikaelDirector · Common StockSold 1 600 @ $135,42$217K · 2026-05-29
    • Buckner Michael StevenSenior Vice President · Common StockOther 8 872 · 2026-05-19
    • MAY SIMONSenior Vice President · Common StockOther 368 @ $115,62$43K · 2026-05-08
    • Henson MeghanSenior Vice President · Common StockOther 153 @ $113,98$17K · 2026-03-31
    • BRAWLEY OTIS WDirector · Common StockOther 2 158 @ $111,75$241K · 2026-03-19
    • SCANGOS GEORGE ADirector · Common StockOther 2 158 @ $111,75$241K · 2026-03-19
    • SCANGOS GEORGE ADirector · Common StockOther 1 057 @ $111,75$118K · 2026-03-19
    • BRAWLEY OTIS WDirector · Common StockOther 888 @ $111,75$99K · 2026-03-19
    • Rataj Sue H.Director · Common StockOther 2 158 @ $111,75$241K · 2026-03-19

    Short positioning

    5.7Mshares short+8.5% vs prior
    2.51days to cover
    57.3%short of daily vol
    660fails-to-deliver
    as of 2026-06-15 · short-interest report (free)
    Index membership
    S&P 500United States

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    A.OCanonical
    NYSE · USD

    Intel & risk

    PredictorBeat prob33 %Surprise-0,02M&A prob3 %Full forecast →
    peak dispatch · 2026-06-25
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.
    Relationship graph
    AEX21:05bEX21:283EX21:2d3EX21:3f5EX21:518EX21:62cEX21:ac2EX21:b63EX21:eddEX21:f73Unclassified
    This companySectorSubsidiaries

    Evidence & claims

    From filings & derived data
    • Total liabilities (YoY) (2026-01-31 vs 2025-01-31): 0.3%Derived (calculated)
    • Total assets (YoY) (2026-01-31 vs 2025-01-31): 7.5%Derived (calculated)
    • Cash & equivalents (YoY) (2026-01-31 vs 2025-01-31): 19.8%Derived (calculated)
    • Shareholders' equity (YoY) (2026-01-31 vs 2025-01-31): 14.6%Derived (calculated)
    • Long-term debt (YoY) (2026-01-31 vs 2025-01-31): -8.9%Derived (calculated)
    • Debt-to-equity (FY 2026-01-31): 0.85xDerived (calculated)
    • Current ratio (FY 2026-01-31): 2.07xDerived (calculated)
    • Total liabilities (annual): USD 5.91BSEC XBRL filing
    • Shares outstanding (annual): 282.7MSEC XBRL filing
    • Long-term debt (annual): USD 3.05BSEC XBRL filing
    • Current liabilities (annual): USD 2.23BSEC XBRL filing
    • Total assets (annual): USD 12.81BSEC XBRL filing
    • Current assets (annual): USD 4.62BSEC XBRL filing
    • Cash & equivalents (annual): USD 1.76BSEC XBRL filing
    • Shareholders' equity (annual): USD 6.91BSEC XBRL filing
    • Operating cash flow (YoY) (2025-10-31 vs 2024-10-31): -11.0%Derived (calculated)
    • Operating income (YoY) (2025-10-31 vs 2024-10-31): -0.6%Derived (calculated)
    • R&D expense (YoY) (2025-10-31 vs 2024-10-31): -5.0%Derived (calculated)
    • Revenue (YoY) (2025-10-31 vs 2024-10-31): 6.7%Derived (calculated)
    • Capex (YoY) (2025-10-31 vs 2024-10-31): 7.7%Derived (calculated)
    • EPS (basic) (YoY) (2025-10-31 vs 2024-10-31): 3.4%Derived (calculated)
    • Net margin (FY 2025-10-31): 18.8%Derived (calculated)
    • EPS (diluted) (YoY) (2025-10-31 vs 2024-10-31): 3.2%Derived (calculated)
    • Cost of revenue (YoY) (2025-10-31 vs 2024-10-31): 11.1%Derived (calculated)
    Showing 24 of 60 surfaced claims.
    Atomic claims from regulatory filings and derived calculations. Provenance shown as source kind only.

    The Thread

    Everything we know, in order
    2026-08-28EVENTUpcomingQ3 2026 earnings (expected) estimated date
    2026-07-07 05:15 UTCSAGATech and Retail Earnings Volatility Hims & Hers and Shake Shack shares plummet on earnings misses while Meta and Google intensify AI competition.
    2026-07-06 23:40 UTCSAGAAI Chip Market Volatility Samsung profits surge on memory demand while Micron shares plunge, triggering mixed reactions across Indian and South Korean technology indices.
    2026-07-03 07:15 UTCSAGAAI Chip Selloff ECB Pivot Semiconductor stocks plunge amid AI bubble fears while the European Central Bank signals readiness for further rate hikes, challenging dovish market consensus.
    2026-07-01 00:09 UTCNEWSKospi opens 1.36% higher as chip rally extends → South Korean equities continue their upward trajectory, defying broader global tech weakness. The rally is anchored by strong sentiment in the semiconductor sector following Micron's earnings beat.
    2026-06-30 20:47 UTCNEWSMicron, Intel and AMD add $2 trillion in combined value as AI rally broadens beyond Nvidia → Investors widened their semiconductor exposure in the second quarter, driving a record valuation surge for chipmakers outside the Nvidia ecosystem.
    2026-06-30 18:50 UTCNEWSNvidia lags peers as chip sector posts record quarter → The AI chip leader underperformed a broader semiconductor rally driven by memory and foundry strength, raising questions about valuation limits.
    2026-06-30 17:11 UTCNEWSAI investment cycle shifts focus to memory chips as demand surges → Wall Street is reassessing the semiconductor landscape as the AI infrastructure build-out moves beyond GPUs into high-bandwidth memory, following Micron's recent results.
    2026-06-30 15:11 UTCNEWSSemiconductor rally stalls as AI valuation concerns weigh on chip stocks → AI-fuelled chip stock rally hits speed bump despite record quarterly gains.
    2026-06-30 13:56 UTCNEWSUS equities on track for strongest quarterly rally in six years → Futures point to a positive open as broad-based gains in tech and energy sectors push major indices toward record-breaking second-quarter returns.
    2026-06-30 12:07 UTCNEWSBernstein upgrades Micron outlook as memory chip maker posts eightfold 2026 rally → The investment bank maintains an outperform rating on the stock, citing continued momentum following the company's recent earnings beat and strong guidance.
    2026-06-30 04:45 UTCNEWSAsian equities on track for strongest quarter in nearly two decades → Regional markets close out a record-breaking second half, buoyed by robust earnings from US semiconductor giants Micron and Qualcomm that helped dispel investor anxiety.
    2026-06-30 03:38 UTCEARNINGSUpcomingForecast: earnings_forecast (365d)
    2026-06-30 03:38 UTCEARNINGSUpcomingForecast: earnings_forecast (365d)
    2026-06-30 03:38 UTCEARNINGSUpcomingForecast: earnings_forecast (365d)
    2026-06-30 03:38 UTCEARNINGSUpcomingForecast: earnings_forecast (365d)
    2026-06-30 03:38 UTCEARNINGSUpcomingForecast: earnings_forecast (365d)
    2026-06-30 03:38 UTCEARNINGSUpcomingForecast: earnings_forecast (365d)
    2026-06-30 03:38 UTCEARNINGSUpcomingForecast: ma_probability (180d)
    2026-06-29 20:13 UTCSAGATech Selloff Spreads Globally Nasdaq futures slide as AI spending concerns and South Korean tech weakness trigger a broad-based equity rout across US and Asian markets.
    2026-06-28 21:51 UTCNEWSMicron market cap tops $1.3 trillion as AI memory shortage fuels rally → Shares surged 18.4% to $1,236, briefly surpassing Meta and Tesla in valuation as investors price in persistent supply constraints for AI data centers.
    2026-06-28 18:00 UTCNEWSSemiconductor rally broadens as analysts highlight CPU demand surge → UBS points to hyperscale cloud providers driving a shift toward CPU-intensive workloads, lifting shares of AMD and ARM alongside Micron's recent momentum.
    2026-06-28 14:03 UTCNEWSMicron poised to join Nvidia and Google at the top of U.S. corporate profitability → Memory chip maker's surging margins reflect the structural shift in data-center economics, reinforcing the sector's rally.
    2026-06-28 03:45 UTCEARNINGSUpcomingForecast: fundamentals_forecast (365d)
    2026-06-27 16:44 UTCNEWSOil prices retreat as Wall Street rotates out of AI tech → Brent crude fell sharply this week, providing a tailwind for inflation expectations even as skepticism over AI valuations weighed on equities.
    2026-06-26 13:30 UTCNEWSChinese chipmakers surge on debut as $1bn IPOs signal capital market resilience → Strong opening gains for two semiconductor listings in Hong Kong underscore investor appetite for the sector, following a broader rally across Asian tech equities.
    2026-06-26 12:33 UTCNEWSUS equity futures slide as global tech sell-off resumes → Nasdaq futures drop 1.1% and S&P 500 futures fall up to 1%, extending a multi-day retreat in technology stocks despite Micron's strong earnings.
    2026-06-26 12:08 UTCNEWSMicron shares trade near $1,028 as analysts flag valuation reset ahead of Q3 earnings → Wall Street sees a potential inflection point for the memory chip maker, arguing current multiples are disconnected from the AI-driven demand cycle.
    2026-06-26 08:03 UTCNEWSMicron results signal shift in how Wall Street prices AI memory demand → Explosive quarterly performance suggests a structural repricing of the memory sector, with implications for broader AI infrastructure valuations.
    2026-06-26 00:00 UTCINSIDER2 insider transactions — 2026-06
    2026-06-26 00:00 UTCINSIDER2 insider transactions — 2026-06
    2026-06-26INSIDERKIRKWOOD JONAH PREVOST transacted 30 sh — Senior Vice President ~$4k
    2026-06-25 22:14 UTCNEWSBHP-backed I-Pulse secures $250 million US CHIPS Act award for silicon-carbide expansion → The funding underscores Washington's push to diversify power electronics supply chains, adding to a day of strong semiconductor sector momentum.
    2026-06-25 21:31 UTCNEWSNasdaq extends slide as Apple sells off; oil rises on Hormuz risk → Tech weakness drags the Nasdaq to a fourth straight loss while energy prices gain ground amid persistent shipping concerns in the Strait of Hormuz.
    Showing the 40 most recent of 124 entries.
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-07-07 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data · Reference data Premium coverage